Name: Role of ΔNp73 in oxaliplatin chemoresistance in colo-rectal cancer (en Inglés)
SKU: 57510833
Price: 944.56 MXN
Availability: InStock
Author: Sendino Garví, Elena
ISBN: 9786202120104

portada Role of ΔNp73 in oxaliplatin chemoresistance in colo-rectal cancer (en Inglés)

Role of ΔNp73 in oxaliplatin chemoresistance in colo-rectal cancer (en Inglés)

Formato

Libro Físico

Autor

Elena Sendino Garví

Editorial

Editorial Academica Espanola

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.3 cm

Peso

0.09 kg.

ISBN13

9786202120104

Categorías

Biología, ciencias de la vida

Role of ΔNp73 in oxaliplatin chemoresistance in colo-rectal cancer (en Inglés)

Elena Sendino Garví (Autor) · Editorial Academica Espanola · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

$ 1,717.38$ 944.56

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 944.56

¡Envío Gratis! Llega entre el 03 Dic y el 11 Dic a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Role of ΔNp73 in oxaliplatin chemoresistance in colo-rectal cancer (en Inglés)"

Colorectal cancer is one of the most frequent types of cancer and has one of the highest mortality rates. As in all types of cancer, neoplasia is due to multiple factors, among which the environmental factor and the genetic factor stand out. The TP73 gene has been reported to be involved in colorectal cancer. Belonging to the TP53 gene family, it encodes multiple isoforms, such as TAp73 or ΔNp73, with opposite functions in the colorectal cancer carcinogenesis process. One of the isoforms, which is the subject of this study, ΔNp73, has been over-expressed in processes of tumorigenesis, as well as a potential cause of the resistance of cancer cells, contributing to a lower survival of patients with colorectal cancer. In this work, the over-expression of ΔNp73 has been identified as one of the possible causes of resistance by cancer cells to treatment with oxaliplatin (compound used in cancer chemotherapy), through the potential activation of the autophagy pathway, through the possible induction of the HMGB-1 gene, fact by means of which said resistance to oxaliplatin could be developing.